Amplia Therapeutics Limited

ASX:ATX.AX

0.235 (AUD) • At close July 3, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.

2025 Q22024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q2
Omzet 1.4072.0042.448-0.581.7691.2210.7630.6740.860.0340-00.051-0.0770.6570.6161.1821.4470.8170.0150.0150000
Kosten van de omzet 0.0710.3310.0430.0440.0290.0020.00200000.0790.0770.0220.080.0750.1310.1140.1360.1190.11900.1670.1180.118
Brutowinst 1.3361.6742.405-0.6241.741.2190.7610.6730.860.034-0-0.079-0.026-0.10.5770.5411.0511.3320.681-0.104-0.1040-0.167-0.118-0.118
Brutowinstmarge 0.950.8350.9821.0770.9840.9990.9980.99910.9880187.19-0.5111.2910.8780.8790.8890.9210.834-6.852-6.8520000
Onderzoek- en ontwikkelingskosten 2.83.6112.1941.1583.5292.4711.3021.4610.750.7580.3130.5420.1361.1962.0293.1482.8883.3051.4421.0211.0210.3240.3240.3870.387
Algemene en administratieve kosten 1.2691.3891.2151.2050.9930.9040.7320.6340.5010.4060.4530.3940.4670.5380.8150.7310.7330.6280.6190.8010.8010.8730.8730.3630.363
Verkoop- en marketingkosten 0.0670.040.1580.3880.1280.1650.050.3510.1770.2050.1220.1470.0970.0340.1580.1440.1530.1420.1290.070.0700.0520.1070.107
Verkoop-, algemene en administratieve kosten 1.3361.4291.3731.5941.1211.0690.7820.9850.6780.6110.5750.5410.5640.5751.0451.0491.6410.8520.8950.8010.801-0.2141.960.470.47
Overige kosten -0.041-0.023000000000000000000.0150.01500.02800
Bedrijfskosten 4.0955.0163.5672.7524.653.542.0842.4461.4281.370.8891.0840.7011.7133.0894.1834.5474.1772.8542.7152.7150.113.9781.291.29
Bedrijfsresultaat -2.759-3.342-3.61-2.796-4.679-3.542-2.085-2.446-1.429-1.37-0.889-1.163-0.727-1.813-2.512-3.642-3.496-2.844-2.173-2.699-2.699-2.044-2.044-1.515-1.515
Bedrijfsresultaat ratio -1.961-1.668-1.4744.822-2.644-2.901-2.735-3.632-1.661-40.03202,756.372-14.28523.517-3.821-5.914-2.957-1.966-2.661-178.107-178.1070000
Totaal overige inkomsten en kosten netto -0.055-2.0210.0320.0460.039-0.0010-0.1620.0570.0020.0040.0110.0080.0110.0010.048-0.0040.0360.0380.0810.081-0.203-0.232-0.179-0.179
Inkomen voor belasting -2.814-5.364-3.578-2.751-4.64-3.542-2.085-2.444-1.371-1.368-0.885-1.152-0.718-1.802-2.495-3.594-3.482-2.808-2.135-2.619-2.619-2.248-2.247-1.694-1.694
Inkomen voor belasting ratio -2-2.676-1.4614.743-2.622-2.902-2.735-3.628-1.594-39.98102,730.227-14.10323.379-3.796-5.836-2.945-1.941-2.615-172.787-172.7870000
Belastingkosten 0-1.989-2.4480.58-1.728-1.221-0.763-0.674-0.86-0.034-000000000-0.081-0.0810.0430.47800
Nettowinst -2.814-3.374-1.129-3.331-2.912-2.322-1.323-1.77-0.511-1.334-0.885-1.152-0.718-1.802-2.495-3.594-3.482-2.808-2.135-2.619-2.619-2.248-2.247-1.694-1.694
Nettowinstmarge -2-1.683-0.4615.743-1.646-1.902-1.735-2.628-0.594-38.98102,730.227-14.10323.379-3.796-5.836-2.945-1.941-2.615-172.787-172.7870000
WPA (Winst Per Aandeel) -0.011-0.017-0.006-0.017-0.015-0.014-0.011-0.016-0.006-0.018-0.017-0.028-0.019-0.08-0.11-0.16-0.17-0.15-0.12-0.13-0.13-0.174-0.166-0.1-0.1
Verwaterde WPA -0.011-0.017-0.006-0.017-0.015-0.014-0.011-0.016-0.006-0.018-0.017-0.028-0.019-0.08-0.11-0.16-0.17-0.15-0.12-0.13-0.13-0.174-0.166-0.1-0.1
EBITDA -2.8-3.441-1.118-2.669-2.88-3.54-2.084-2.443-1.428-1.37-0.885-1.162-0.726-1.808-2.496-3.622-3.478-2.793-1.656-1.844-1.844-1.264-1.353-0.742-0.742
EBITDA ratio -1.99-1.717-0.4574.602-1.628-2.9-2.733-3.627-1.661-40.0202,754.488-14.26923.454-3.797-5.882-2.942-1.93-2.028-121.689-121.6890000